HHS/DoJ WOULD ISSUE "ADVISORY OPINIONS" ON LEGALITY OF SUPPLIER-PROVIDER DEALS UNDER INSURANCE REFORM MEASURE; RISK-SHARING PROTECTION ALSO INCLUDED
This article was originally published in The Gray Sheet
Executive Summary
Health care-suppliers and providers could receive federal "advisory opinions" on the legality of their business arrangements under an anti-fraud provision in the health insurance reform legislation (HR 3103) reported out of a House/Senate conference committee July 31. The bill was adopted by the House on Aug. 1, followed by the Senate on Aug. 2.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.